Literature DB >> 21641758

Pulmonary embolism prophylaxis in more than 30,000 total knee arthroplasty patients: is there a best choice?

Monti Khatod1, Maria C S Inacio, Stefano A Bini, Elizabeth W Paxton.   

Abstract

Prophylaxis for pulmonary embolism (PE) prevention in total knee arthroplasty remains controversial. A joint registry evaluated venous thromboembolism prophylaxis and anesthesia impact on the incidence of PE, fatal PE, and death. Patients received mechanical prophylaxis alone or chemical with or without mechanical prophylaxis. The overall PE incidence was 0.45%; fatal PE, 0.01%; and death, 0.31%. The only significant difference in any outcome was the incidence of PE between Coumadin and mechanical prophylaxis alone. Variables associated with a higher incidence of PE were age, an American Society of Anesthesiologists score of 3 or higher, and the use of general anesthesia. Based on the findings, general anesthesia can be discouraged, and only Coumadin fared better than mechanical prophylaxis alone, whereas other forms of chemical prophylaxis revealed no significant differences.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21641758     DOI: 10.1016/j.arth.2011.04.006

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  7 in total

1.  The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.

Authors:  Janet N Chu; Judith Maselli; Andrew D Auerbach; Margaret C Fang
Journal:  Thromb Res       Date:  2017-04-12       Impact factor: 3.944

2.  Mobile Compression Reduces Bleeding-related Readmissions and Wound Complications After THA and TKA.

Authors:  Diren Arsoy; Nicholas J Giori; Steven T Woolson
Journal:  Clin Orthop Relat Res       Date:  2018-02       Impact factor: 4.176

3.  The Kaiser Permanente implant registries: effect on patient safety, quality improvement, cost effectiveness, and research opportunities.

Authors:  Elizabeth W Paxton; Maria Cs Inacio; Mary-Lou Kiley
Journal:  Perm J       Date:  2012

4.  Thromboembolic prophylaxis in total joint arthroplasty.

Authors:  David Knesek; Todd C Peterson; David C Markel
Journal:  Thrombosis       Date:  2012-09-16

5.  Thromboprophylaxis for deep vein thrombosis and pulmonary embolism after total joint arthroplasty in a low incidence population.

Authors:  Kang-Il Kim; Dong-Geun Kang; Sumit S Khurana; Sang-Hak Lee; Young-Joo Cho; Dae-Kyung Bae
Journal:  Knee Surg Relat Res       Date:  2013-05-29

6.  Thromboprophylaxis only during hospitalisation in fast-track hip and knee arthroplasty, a prospective cohort study.

Authors:  Christoffer C Jørgensen; Michael K Jacobsen; Kjeld Soeballe; Torben B Hansen; Henrik Husted; Per Kjærsgaard-Andersen; Lars T Hansen; Mogens B Laursen; Henrik Kehlet
Journal:  BMJ Open       Date:  2013-12-10       Impact factor: 2.692

Review 7.  Aspirin and the prevention of venous thromboembolism following total joint arthroplasty: commonly asked questions.

Authors:  I Azboy; R Barrack; A M Thomas; F S Haddad; J Parvizi
Journal:  Bone Joint J       Date:  2017-11       Impact factor: 5.082

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.